Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has announced that it will be hosting a virtual roadshow next month. The event is scheduled for 11 a.m. ET on Wednesday, Feb. 3, 2021. Trxade Group CEO Suren Ajjarapu will host the presentation, which will include an overview of the company’s business model and an outline of growth initiatives. The webinar will also include a question-and-answer session. The entire presentation can be accessed via webcast link or dial-in numbers. Those interested in the webcast can register before the event, then sign in to view the presentation on the day of the event. Those interested in listening to the presentation can call 1-844-512-2921 within the United States or 1-412-317-6671 internationally. Those calling in should dial in at least 10 minutes before the presentation begins. In addition, the webcast will be available for replay through Feb. 17, 2021, by calling 1-844-512-2921 within the United States or 1-412-317-6671; enter replay pin number 13714981. The webcast will also be available for 90 days on the IR section of the Trxade Group website.
To register for and view the full webcast, visit https://ibn.fm/Q7m5p
To view the full press release, visit https://ibn.fm/pPIpp
About Trxade Group Inc.
Headquartered in Tampa, Florida, Trxade Group is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with around 11,800 registered pharmacies; (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division; and (3) the Bonum Health platform offering affordable telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
